Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://www.sentinelinitiative.org/news-events/publications-presentations/hydroxyurea-utilization-patterns-among-sickle-cell-disease	Hydroxyurea Utilization Patterns Among Sickle Cell Disease Patients in the United States, US FDA Sentinel Database	Publications and Presentations	11/29/2018	Hydroxyurea Utilization Patterns Among Sickle Cell Disease Patients in the United States, US FDA Sentinel Database Publications and Presentations 11/29/2018
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2016	Duration of Follow Up for New Molecular Entities Approved in 2016	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2016 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2014-and	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2010-2012	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2008-and	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2005-2006	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 Analyses 04/16/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2011	Duration of Follow Up for New Molecular Entities Approved in 2011	Analyses	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2011 Analyses 04/16/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/extending-machine-learning-methods-development-sentinel-follow-analyses	Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3)	Methods, Data, & Tools	05/17/2021	Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3) Methods, Data, & Tools 05/17/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/who-gets-treated-influenza-surveillance-study-us-food-and	Who Gets Treated for Influenza: A Surveillance Study From the US Food and Drug Administration’s Sentinel System	Publications and Presentations	08/05/2021	Who Gets Treated for Influenza: A Surveillance Study From the US Food and Drug Administration’s Sentinel System Publications and Presentations 08/05/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-drugs-approved-risk-evaluation-and-mitigation	Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU)	Assessments	08/23/2021	Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) Assessments 08/23/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs	Methods, Data, & Tools	09/24/2021	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2021-13th-annual-sentinel-initiative-public-workshop	2021 13th Annual Sentinel Initiative Public Workshop	Sentinel Initiative Events	11/08/2021	2021 13th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events 11/08/2021
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/thromboembolic-stroke-algorithm-defined-1	Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis"	Methods, Data, & Tools	01/06/2022	Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis" Methods, Data, & Tools 01/06/2022
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-bleeding-algorithm-defined-0	Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis"	Methods, Data, & Tools	01/06/2022	Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis" Methods, Data, & Tools 01/06/2022
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-extracranial-bleeding-algorithm-defined-1	Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis"	Methods, Data, & Tools	01/06/2022	Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis" Methods, Data, & Tools 01/06/2022
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intracranial-hemorrhage-algorithm-defined-1	Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis"	Methods, Data, & Tools	01/06/2022	Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 and Older: An IPTW Analysis" Methods, Data, & Tools 01/06/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019	Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis	Analyses	01/26/2022	Duration of Follow Up for New Molecular Entities Approved in 2019: A Descriptive Analysis Analyses 01/26/2022
https://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter	Quarterly Newsletter	Spotlight	03/24/2022	Quarterly Newsletter Spotlight 03/24/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydroxyurea-use-among-patients-sickle-cell-disease-scd	Hydroxyurea Use Among Patients with Sickle Cell Disease (SCD): A Descriptive Analysis	Analyses	03/29/2022	Hydroxyurea Use Among Patients with Sickle Cell Disease (SCD): A Descriptive Analysis Analyses 03/29/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-major-extracranial-bleeding-0	Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 or Older: An Inverse Probability of Treatment Weighting (IPTW) Analysis	Analyses	04/25/2022	Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 or Older: An Inverse Probability of Treatment Weighting (IPTW) Analysis Analyses 04/25/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-public-training-day-inverse-probability	2022 Sentinel Public Training Day: Inverse Probability of Treatment Weighting & Innovation Day	Sentinel Initiative Events	04/28/2022	2022 Sentinel Public Training Day: Inverse Probability of Treatment Weighting & Innovation Day Sentinel Initiative Events 04/28/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment	Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis	Analyses	05/16/2022	Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis Analyses 05/16/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health	Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes	Methods, Data, & Tools	06/01/2022	Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes Methods, Data, & Tools 06/01/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/bamlanivimab-bamlanivimab-and-etesevimab-and-casirivimab	Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis	Analyses	06/14/2022	Bamlanivimab, Bamlanivimab and Etesevimab, and Casirivimab-Imdevimab Use in Patients with COVID-19: A Descriptive Analysis Analyses 06/14/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterizing-pregnant-women-and-without-evidence-heart	Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis	Analyses	06/21/2022	Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis Analyses 06/21/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use	Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis	Analyses	06/24/2022	Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: A Descriptive Analysis Analyses 06/24/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/hospitalization-and-anaphylaxis-following-monoclonal	Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis	Analyses	07/14/2022	Hospitalization and Anaphylaxis Following Monoclonal Antibodies (mAb) Use in Patients with COVID-19: A Descriptive Analysis Analyses 07/14/2022
https://www.sentinelinitiative.org/studies/drugs/women-heart-failure	Women with Heart Failure & Pregnancy	Studies	08/10/2022	Women with Heart Failure & Pregnancy Studies 08/10/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-monoclonal-antibodies-mabs-under-emergency-use-0	Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: An Updated Descriptive Analysis	Analyses	08/24/2022	Use of Monoclonal Antibodies (mAbs) Under an Emergency Use Authorization (EUA) in Patients with COVID-19 Diagnosis: An Updated Descriptive Analysis Analyses 08/24/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-pediatric-members-sentinel-distributed	Characterizing Pediatric Members in the Sentinel Distributed Database	Publications and Presentations	08/28/2022	Characterizing Pediatric Members in the Sentinel Distributed Database Publications and Presentations 08/28/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2	Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis	Analyses	11/10/2022	Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis Analyses 11/10/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-14th-annual-sentinel-initiative-public-workshop	2022 14th Annual Sentinel Initiative Public Workshop	Sentinel Initiative Events	11/15/2022	2022 14th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events 11/15/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/scalable-phenotyping-safety-outcomes-using-electronic-health	Scalable Phenotyping for Safety Outcomes Using Electronic Health Record Data	Publications and Presentations	11/17/2022	Scalable Phenotyping for Safety Outcomes Using Electronic Health Record Data Publications and Presentations 11/17/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-zarxio-use-updated-signal	Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis	Analyses	03/08/2023	Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis Analyses 03/08/2023
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-public-training-signal-identification-among	2023 Sentinel Public Training: Signal Identification Among Infants Following Maternal Medication Use During Pregnancy & Innovation Day	Sentinel Initiative Events	04/11/2023	2023 Sentinel Public Training: Signal Identification Among Infants Following Maternal Medication Use During Pregnancy & Innovation Day Sentinel Initiative Events 04/11/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/r-package-perform-routine-structural-missing-data	An R Package to Perform Routine Structural Missing Data Investigations in Real-World Data	Publications and Presentations	06/06/2023	An R Package to Perform Routine Structural Missing Data Investigations in Real-World Data Publications and Presentations 06/06/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/signal-detection-and-refinement-activities-within-fda-s-0	Signal Detection and Refinement Activities within FDA’s Sentinel System	Publications and Presentations	06/28/2023	Signal Detection and Refinement Activities within FDA’s Sentinel System Publications and Presentations 06/28/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-cannabis-derived-product-users-trinetx-four	Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses	Analyses	07/19/2023	Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses Analyses 07/19/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-descriptive	Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis	Analyses	07/19/2023	Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis Analyses 07/19/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-updated	Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis	Analyses	07/19/2023	Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis Analyses 07/19/2023